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Abstract 
Objective: The purpose of this project was to determine if there is a need for a palliative 
care team (PCT) to which primary care medical professionals can refer patients. The 
specific objectives of this project were: 1. To assess the knowledge of primary care 
providers regarding palliative care. 2. To assess the value and need for palliative care 
from the PCPs’ perspective. 3. To evaluate the current ED utilization data for adults with 
serious chronic illness.  
Methods: This was a descriptive study that involved an analysis of ED visit data for 
chronic illness, and a survey all PCPs employed at this healthcare system.  
Results: Key findings showed that this population of providers were highly 
knowledgeable of palliative care (PC). The survey questions were answered correctly 
between 84%- 100% of the time. From this sample of PCPs, 89% felt that PC is needed 
and would refer their patients to a PCT if it were available. For the ED utilization data, 
revealed Caucasians and females were the most common users of the ED. Average LOS 
was approximately 4.45 days and HTN was the most common diagnosis. The admission 
rate for patients arriving through the ED was 63% (n = 1,524). Medicare was the primary 
payor for 57% (n = 1,375) of the population with a mean cost per patient of $25,515.84. 
Total cost for the hospital system from October 1, 2017 through December 31, 2017 was 
$58,430,933.75.  
Conclusion: The evidence provided by this project demonstrates that PCPs have a high 
knowledge of PC and do find it to be of value for patients. Also, this study substantiates 
the evidence that patients are having complications from their chronic illnesses that bring 
them to the ED.  These findings support palliative care as a necessary and valued 
modality of healthcare.  
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Background 
Chronic illness affects many Americans at some point in their life, whether they 
are the one suffering from the illness or they are the caregivers of a loved one with the 
illness. A chronic illness is any diagnosis that “lasts longer than 6 months and requires 
ongoing care, cannot be cured, limits activity, and the associated symptoms lead to 
increased rates of morbidity and mortality” (Bushor et al. 2015, p 285). Chronic illnesses 
are associated with an estimated $38 billion in unnecessary emergency department (ED) 
visits, $25 billion in avoidable 30-day hospital readmissions, 67 million annual visits to 
the ED, and 836,000 annual unintentional 30-day readmissions (National Quality Forum, 
2010). Current research continually proves that healthcare is inadequate for the problems 
that the seriously chronically ill patient can experience.  
Chronic disease affects the majority of Americans, 51% of adults have at least one 
chronic condition, and 26% live with multiple chronic diseases (NCSL, 2013).  The 
economic effects of chronic illnesses are not simply higher costs of health care but also 
include the decreased financial efficiency caused by higher rates of absences and poor job 
performances. A study by the Milken Institute found that the seven most common chronic 
diseases (cancer, diabetes, hypertension, stroke, heart disease, respiratory conditions, and 
mental disorder) cost the United States economy almost $1.3 trillion annually, including 
$277 billion for chronic illness treatments and $1 trillion in lost productivity (DeVol et 
al., 2007).  
When it comes to the last two months of life, 27% to 39% patients visit the ED at 
some point to receive relief from their symptoms (Murphy, et al. 2013).  Common 
reasons that chronically ill patients are ultimately admitted to an inpatient setting include 
poor pain control, poor symptom management, an unexpected change in physical 
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condition, and overall caregiver burden (Murphy, et al. 2013). Indicators of poor-quality 
care are inadequately managed symptoms that result in ED visits, hospital and intensive 
care unit (ICU) admission, and possibly death (Earle, et al, 2003). Many studies 
consistently show that chronically ill patients often use health care resources, such as the 
ED, for management of their needs (Beckstrand et al., 2006; Bushor et al. 2015; Earle, et 
al, 2003; Hui et al. 2014; Murphy et al, 2013).  Although most Americans would prefer to 
die at home, many continue to die with pain and poorly managed symptoms in a hospital 
setting (Beckstrand et al., 2006). More than 2.4 million deaths are annually recorded in 
the United States, and most of these deaths (80%) occur in hospitals (Murphy et al., 
2013). Additionally, 20% of ICU patients die while hospitalized (Murphy et al., 2013).  
Instead of realizing that death is a natural part of life, the majority of citizens in 
the United States deny death and won’t accept that they will die at some point in their 
life. There is much reliance in believing that medical science can and will save us 
regardless of life’s natural course. Frequently, healthcare providers perceive death as 
somehow failing to heal their patient rather than accepting the natural aspect of life. This 
tends to be manifested in a lack of discussions with patients regarding their end of life 
plan and wishes (End-of-Life Nursing Education Consortium, 2018).  These discussions 
are missed opportunities to address the emotional, social, spiritual and physical pain with 
chronically ill patients and families. These conversations can improve quality of life for 
patients and families (National Hospice and Palliative Care Organization, n.d.).  
Palliative care is a specialized modality of healthcare that focuses on 
providing relief from the symptoms and stress of a serious illness (The Center to Advance 
Palliative Care, n.d.).  It is appropriate at any age, at any stage of illness, and can be 
offered together with curative treatment for any patient living with a serious illness 
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(CAPC, n.d.).  Palliative care is a collaboration of doctors, nurses, social workers and 
others who work together to improve quality of life by:  anticipating, preventing, and 
treating suffering; providing clarity on medical decisions; and by providing a plan of care 
for patients, families, and all medical providers (Dalal,et al, 2017).  
According to the National Palliative Care Research Center (NPCRC) “palliative 
care is specialized medical care for people with serious illnesses. It is focused on 
providing patients with relief from the symptoms, pain, and stress of a serious illness, 
whatever the diagnosis” (NPCRC, n.d.). Research findings demonstrate that initiating 
palliative care as early as possible in the outpatient setting is beneficial because it has 
been proven to decrease ED utilization and hospital admissions for those patients with 
life-limiting illness (Murphy, et al, 2013). 
The former model of PC primarily included PC when death was imminent (Figure 
1).  The current updated, evidence-based model of PC involves PC at the time of 
diagnosis, but the involvement is not at prominent as it is near the end of the illness 
(Figure 2).  There is a steady decline of traditional care while there is a steady increase in 
PC, which eventually converts into hospice care.  Bereavement is also included for the 
surviving family and caregivers after the patient’s death.  PC encompasses the broader 
population that could benefit from receiving this practice of care earlier in their illness or 
disease process (NHPCO, n.d.).  
The objectives of palliative care are to improve the quality of a seriously ill 
person's life and to support that person and their family during and after treatment with an 
overall goal to create a plan of care for all involved (NPCRC, n.d.). Palliative care (PC) is 
a resource that can save patients the distress of needless procedures, medications, hospital 
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stays, and false hope that brings about unnecessary anxiety, pain, and fear (Aldridge et al, 
2016).   
However, at the healthcare system for this study, only two of the four hospitals 
have an inpatient PC team that is generally consulted too late in the disease progression, 
when further treatment is no longer an option and hospice is warranted.  Hospice is a 
subdivision of palliative care that is specifically designed for patients who are in their last 
six months of life and have opted for no further treatments but want to focus on comfort 
from pain and anxiety (American Academy of Hospice and Palliative Medicine, n.d.).  A 
primary palliative care team would be able to be involved throughout the course of the 
illness, rather than only being there for the end. In view of this, the intention of this study 
is to determine if there is a need for a palliative care team that can be consulted in the 
outpatient setting at the time of diagnosis, to improve patient quality of life and decrease 
overall healthcare costs. 
Theory 
The Human to Human Relationship Model, developed by Joyce Travelbee, is 
based on existentialism and its belief that humans are unique and irreplaceable, 
constantly growing, changing, facing conflicts and choices, and needing to accept 
accountability of these.  This model, which is a major contribution to psychiatric and 
hospice nursing, can appropriately be utilized for all specialties in the nursing arena. 
The Human to Human Relationship Model of Nursing has five phases. 
• The inaugural meeting or original encounter  
• Visibility of personal identities/ emerging identities.  
• Empathy 
• Sympathy 
• Establishing mutual understanding and contact/ rapport (Nursing Theories, 
n.d.)  
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The role of nursing in Travelbee's theory is to help the patient find meaning in the 
experience of suffering, as well as help the patient maintain hope. It is necessary for the 
nurse to interact with the patient by using an authentic, humanistic approach. Patients are 
experiencing an imbalance of their health and the key to regain homeostasis is for the 
nurse to determine what has brought on this imbalance.  By building a relationship that 
has followed the steps of interaction as Travelbee theorized, then the relationship can 
sustain through the illness and that connection will stimulate the nurse to go above and 
beyond for the patients that they have an emotional connection with.  A nurse, that 
follows the seven basic concepts of Travelbee’s theory will be able to assist the patient 
with their health issues and to accept and learn from it.  This in turn will motivate the 
patient to change their behavior, maintain their health, and accept accountability for their 
actions that initiated the illness to begin with. 
The main concept that is of the utmost importance of the Human to Human 
Theory is the maintaining of hope.  A patient needs to have hope, whether its hope for a 
speedy recovery or hope for all their loved ones to be at their bedside as they take their 
final breath, because it gives them the faith and trust needed to not surrender to their 
illness, but to accept it.   
Purpose   
Research suggests assessing the need for a palliative care team (PCT) can be 
accomplished by studying the use of the ED, hospital admissions, hospital deaths, and 
medical procedures for the seriously chronically ill patient and totaling the overall costs 
(Beckstrand et al., 2006; Bushor et al. 2015; Earle, et al, 2003; Hui et al. 2014; Murphy et 
al, 2013). If the rates of hospital utilization and medical costs are higher than expected, a 
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PCT can be created that may help to cut these costs and improve patient symptom 
management, quality of life, and satisfaction. The specific objectives of this project were: 
1. To assess the knowledge of primary care providers regarding palliative care. 2. To 
assess the value and need for palliative care from the PCPs’ perspective. 3. To evaluate 
the current ED utilization data for adults with serious chronic illness. 
This project’s purpose is also pertinent to the local healthcare organization’s 
mission that aims to provide quality health care to all those who are served in an 
approach that responds to the needs of the communities while honoring the faith heritage 
(Norton Healthcare. n.d.). 
Completing this study will supply needed information to create a PCT for the 
patients who are diagnosed with a life-limiting chronic illness.  By creating a healthcare 
organization that focuses on early PC, there could be a higher quality of overall care 
which has been proven to decrease healthcare costs, while increasing patient satisfaction, 
improving symptom management, quality of life, quality of death, and providing better 
managed care (Hui et al. 2014). When integrated with standard care at time of diagnosis, 
PC improves patient outcomes, including symptom burden, quality of life (QoL), and 
end-of-life care, all with lower associated costs (Dalal,et al, 2017).  More importantly, the 
patient can be reassured that their pain, anxiety, dignity, and final wishes will be 
maintained.  
Methods 
Design 
This was a descriptive study that analyzed ED utilization data and surveyed all 
primary care providers (PCPs) employed at this organization.  
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Setting 
 This project collected data at one institution with a network of five hospitals, and 
30 physician practices. This is the largest healthcare system in Louisville, KY and the 
surrounding region.   
Sample  
There were two populations of interest. The first population was the PCPs 
working at this organization. Three hundred sixteen providers employed in the primary 
care offices were included in this study. Inclusion criteria for PCPs was comprised of all 
primary care providers that are licensed as either a medical doctor (MD), Doctor of 
Osteopathic Medicine (DO), nurse practitioner (NP), or physician assistant (PA); and see 
adult patients. Exclusion criteria were pediatric providers, any unlicensed professionals, 
and PCPs not employed by this system. PCPs’ email addresses were obtained through the 
NHC human resources department (HR), and permission to use PCPs’ email for this 
project was be granted by HR personnel (Appendix C). 
The second sample was comprised of ED utilization data.  This data was from a 
90-day timeframe, beginning October 1, 2017 through December 31, 2017, from all four 
major hospitals of this organization. Inclusion criteria were all adult patients seen in the 
ED with serious life-limiting illness diagnosis of congestive heart failure (CHF), 
hypertension (HTN), end-stage renal disease (ESR), chronic obstructive pulmonary 
disease (COPD), dementia, amyotrophic lateral sclerosis (ALS), acquired 
immunodeficiency syndrome (AIDS); human immunodeficiency virus (HIV), cerebral 
vascular accidents (CVA), and diabetes mellitus (DM) (Appendix F for specific ICD-10 
codes). Exclusion criteria included any patients diagnosed with cancer or malignancies; 
gestational diabetic patients; pediatric patients under 18, and any patient who received a 
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new diagnosis of a life limiting chronic illness during that hospital visit. These medical 
records were excluded for the following reasons: their age and inability to make their 
own decisions without a guardian’s involvement; cancer treatment for oncology patients 
generally include palliative care; and patients with diagnoses made with current hospital 
admission have yet to be seen by their PCPs. Also, excluded were any patients with 
alcohol or drug abuse as these patients generally require detoxification and rehabilitation 
with more involvement from the psychiatric team. 
Measures 
Providers’ survey data was collected via Qualtrics (Qualtrics, 2018). Qualtrics is a 
secure, web-based application that is designed exclusively to support data capture for 
research studies and every effort was taken to safeguard data once received from 
Qualtrics.  
The survey measured knowledge and perception of palliative care, involved 10 
questions, and took approximately 5 minutes or less to complete (Appendix E). Questions 
1-4 were true/false questions and were derived from the palliative care quiz for nursing 
(PCQN) (Ross et al, 1996). Three multiple-choice questions, 5-8, were derived from the 
survey created by the Italian Society of Palliative Care (SICP) and the Italian Society of 
General Practice (SIMG) which have been used in a study of Italian general practitioners 
(Beccaro et al, 2013). The last two questions were yes or no and were created by the 
primary investigator (PI). Additionally, the PI collected demographic data: years of 
experience, and license as MD, DO, NP, or PA.  
ED utilization data: Data was requested through a collaboration with the 
healthcare’s IT/ decision support/clinical effectiveness program. The 90-day review of 
the ED utilization data specified:  
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• Rates of admissions to ED 
• If admitted to the hospital  
• Rates of hospital deaths 
• Admitting diagnosis of: CHF, HTN, ESR, COPD, dementia, ALS, 
AIDS, HIV, CVA, DM  
• Total cost of hospital stays  
• Length of stay  
• Gender 
• Age 
• Ethnicity  
• Insurance status  
 
Data was gathered from all four hospitals within this system from October 1, 2017 
to December 31, 2017.  
Data Collection 
Approvals from this healthcare’s Office of Research and Administration (ORA) 
and the University of Kentucky Institutional Review Board (IRB) were obtained prior to 
data collection (Appendices A, B, & C).  
Primary Care Providers: The PI requested and received email addresses from the 
institution’s human resources department 9,516 were received. Each entry on this list 
supplied the employees’ names, work locations, job titles, and the email addresses of a 
variety of staff from different areas of the healthcare network. Many were excluded due 
to their job title such as those that were staff registered nurses (RN), patient certified 
assistants (PCA), environmental services department (ESD) employees, human resources 
(HR), lab employees, medical care associates (MCA), and secretaries.  Also excluded 
were any providers that worked in the hospital setting which included intensivists, 
hospitalists, nurse practitioners, physician’s assistants, and certified nurse specialists 
(CNS).  Furthermore, providers that were employed in specialty areas, such as maternity, 
spinal medicine, pediatrics, urology, and cardiology were excluded.  The final sample of 
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MD, NP, DO, and PA providers included those employed in the primary care offices 
around the metropolitan area of this specific healthcare system.  The final sample size 
consisted of 316 primary care provider email addresses.  Providers’ email addresses were 
stored in a file separate from data collected from Qualtrics. The providers’ email 
addresses were used for the initial invitation to participate in the survey, then used once 
again for a reminder email that was sent two weeks after the original invitation. After the 
second emailing, the providers’ email address list was destroyed. 
The sample of 316 were sent a first email with a cover letter and informed 
consent, and a request to complete the survey on July 24, 2018.  A second email reminder 
was sent on August 11, 2018.  The survey closed on August 25, 2018.   
Prior to administering surveys, consent for participation was obtained. The email 
contained a cover letter that provided potential participants the informed consent and a 
link to the survey (Appendix D). The informed consent provided a full explanation of the 
study provided, the time commitment required, the option to voluntarily participate or to 
withdraw at any time. It also provided information of the confidentiality associated with 
the study to protect their person from being identified.  They were informed of their right 
to refuse to participate, absence of monetary gains or incentives, and methods of 
communicating concerns regarding the project.  By clicking on the link provided, 
participants were able to continue to the survey and continuing to the survey constituted 
consent to participate.   
The data from Qualtrics was electronically transposed onto a Microsoft excel 
spreadsheet for analysis in IBM SPSS version 23.0.  All research reports were done in 
aggregate form and the data was stored separately on the healthcare’s password protected 
and encrypted H drive.  
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ED utilization data: Data was requested through a collaboration with the 
healthcare’s IT/ decision support/clinical effectiveness program. The 90-day review of 
the ED utilization data was specified for:  
• Rates of admissions to ED 
• If admitted to the hospital  
• Rates of hospital deaths 
• Admitting diagnosis of: CHF, HTN, ESR, COPD, dementia, ALS, 
AIDS, HIV, CVA, DM  
• Total cost of hospital stays  
• Length of stay  
• Gender 
• Age 
• Ethnicity  
• Insurance status  
 
The data that was received from the healthcare’s IT/ decision support/clinical 
effectiveness program contained deidentified information for 2,434 patients, however one 
patient was excluded due to being younger than 18 years of age. The final sample size 
totaled 2,433 patients.  
Data were analyzed using descriptive statistics, including frequency distributions, 
means, and percentages.  
Results 
Providers 
Of the 316 emails that were sent for the initial invitation to participate, 12 were 
not delivered due to email inboxes being full. For the reminder email sent, 13 emails 
were not delivered as one recipient was unknown and the 12 others for the same reason as 
the initial email. Thirty-eight responded to the survey and of those 37 submitted a 
completed survey making the response rate 11.7%.  The professional title of participants 
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were 16 MDs, 3 DOs, and 18 FNPs. Of the 37 who responded, 54% (20) had less than 5 
years’ experience in their role.  
Overall, the results of the survey showed that primary care providers are well 
educated about PC and how it can serve their patients. Survey knowledge questions were 
answered correctly between 84%- 100% of the time.  When answers were cross-tabulated 
using the Chi square test against the specific role of the provider there was no 
significance in answers except for two.   
The first question with a significant result asked, “Do you feel that a palliative 
care team, one you could refer outpatients to, is needed?” Four responded “maybe” and 
those four were MD titled.  The second question of significance asked: If available, 
would you refer your patients to the palliative care team? Again, four responded “no” and 
again those four were MD titled.  Both had a P value of 0.053. More importantly of the 
36 who responded, 32 (89%) felt there was a need for PCT and would refer their patients 
if one was available.  
Of the 37 who did participate, two personally took the time to comment. Both 
applauded the idea of a PCT, praised the project’s objective, and offered help and 
guidance in whatever was needed to create a PCT. 
ED Utilization Data 
During the study timeframe 2,433 patients were seen in the Emergency 
Departments (ED) throughout the four major hospitals. Fifty-six percent of the sample 
were female (n = 1, 365), 65% (n = 1,581) Caucasian, and the age range of the sample 
was between 18 through 101 years, with the mean of 61.6 (sd = 16.8). Of those, 909 were 
seen and discharged from the ED.  The remaining 1,524 patients were admitted with an 
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average length of stay (LOS) of 4.45 days, for a grand total of 6,783 hospital days.  
Twenty-six of these patients expired during their admission (Table 2).  
Total cost, for all ED patients who were admitted from October 1, 2017 through 
December 31, 2017, was $58,430,933.75 with a mean of $25,515.84 per patient (Figure 
4). Cerebral Vascular Accidents (CVA) were the most expensive diagnosis of 
$62,828.96. Medicare was the payor for 57% (n = 1,375) of the population (Figure 3). 
The chief diagnosis was hypertension (HTN) in 37% (n = 910) with 60% (n = 544) of 
those patients being admitted. COPD was the second most common diagnosis at 22.9% 
(n = 556). African Americans had a higher rate of HTN per population, 41% (n = 321).  
Whether ED or inpatient, the mean cost of HTN was $25,715.27 per patient.  
Discussion 
Key findings showed that this population of providers were highly knowledgeable 
of PC. This is dissimilar to those who have taken comparable surveys regarding PC and 
its need (Beccaro et al, 2013; Ross et al, 1996). For the true and false questions one 
through four, which were from the PCQN, this sample scored an average of 89%.  
Research indicated that the average for a sample of 155 registered nurses (RNs) was 76% 
correct which indicates that this population of PCPs is more informed of PC and its value 
(Ross et al, 1996).   On questions five through eight, previous research of 1,489 Italian 
general practitioners that participated received a mean score of 48% (Beccaro et al, 
2013), compared to the 80% received in this study. This sample was exceedingly more 
knowledgeable than providers in previous research from which the survey questions 
originated (Table 1), which could be contributed to recent increased advocacy and 
education for PC.   
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 Eighty-nine percent of this sample of providers felt that PC is needed and would 
refer their patients to a PCT if it were available. This perception of PC is similar to data 
from the World Health Organization (WHO) which states that many providers do 
welcome PC into their practice, however PC continues to remain underutilized (WHO, 
2018).  
National patient data for a three-month time frame during 2015 shows that 
34,236,000 patients utilized the ED (CDC, 2015). However, 17,336,000 shared the same 
primary diagnosis of the chronic illnesses from this study (CHF, HTN, ESR, COPD, 
dementia, ALS, AIDS, HIV, CVA, DM). From the national sample, patients were 
primarily Caucasians 74% (n = 12,854,000); 57.7% (n = 9,995,000) females; 46.7% (n = 
8,093,000) were diagnosed with HTN; and 34.8% (n = 6,031,000) had Medicaid as the 
primary source of payment (CDC, 2015).  The national mean costs per patient was $10, 
885 with total costs of $961,439,280 for a three-month timeframe (HCUP, 2018) and an 
average LOS of 4.6 (HCUP, 2018) (Figure 3).   
These trends do correlate with the data from this project in that whites, females, 
and HTN are the most common users of the ED (Figure 4).  Average LOS was 
approximately the same with 4.9 days of the nation compared to this study’s average 
LOS at 4.45. While HTN was the most common diagnosis for both this study and 
nationally, the second most common for the nation at 21.6% (n = 14,945,000) was 
diabetes (CDC, 2015) while in this study the second most common diagnosis was COPD 
23% (n = 566).  This could be due to the large number of Kentuckians who are smokers. 
Kentucky is ranked second in the nation for smokers (UHF, 2015).  Physiological, 
nicotine is a vasoconstrictor that can lead to HTN, which could explain this area’s high 
rate of the disease.  Furthermore, smoking is the primary cause for COPD, this creates a 
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vulnerable population susceptible to infectious agents and admitting these patients for 
close monitoring of oxygenation requirements is to ensure their safety and viability.  This 
would also account for COPD being the second highest diagnosis in the ED in this study 
and increasing the mean cost per patient to $25,515.84, which is $14,630.84 higher than 
the national mean cost (HCUP, 2018).  
National data shows that the average age was 73 for admissions compared to the 
average of 61.9 of this study (CDC, 2015).  The younger age seen in this study could be 
attributed to Kentucky being the 6th unhealthiest state in the country (UNF, 2015). 
The national admission rate for patients arriving through the ED has been reported 
as 10.5% (n = 1,820) compared to the 63% for this study (NCSL, 2013).  This large 
contrast of admission rates could be due to Kentucky being ranked the fifth state in the 
country that has the highest preventable hospitalizations in the country (United Health 
Foundation, 2015), which can indicate problems with the state’s access to primary health 
care and inadequacies in quality outpatient care (UHF, 2015).  Preventable 
hospitalizations often take place for a failure to treat issues earlier in an outpatient setting 
and are also more common among the uninsured (UHF, 2015).   
Research has shown that early PC can increase satisfaction and quality of life 
(QoL) thereby decreasing the ED usage.  Chronically ill patients who are not well 
managed, which may be the case with those in this study with HTN who use the ED to 
manage symptoms. This also could indicate a decrease in their QoL.  By integrating 
palliative care earlier in an illness progression, there could be a significant impact on 
decreasing unnecessary health care utilization for the patients like those in this study.  
Early PC is beneficial because it has been proven to reduce ER utilization and hospital 
admissions for those patients with life-limiting illness (Hui et al. 2014). The reduction of 
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ER utilization and improved symptom management outside a hospital setting can 
improve quality of life, quality of death, and decrease overall healthcare costs.  
  Palliative care, that is initiated at the time of diagnosis, can be delivered 
alongside treatments that aim to treat the underlying disease (Hawley, 2017).  Both 
approaches are necessary and should have equal value. Research has shown that PCPs 
and patients often have sporadic conversations regarding goals of care. Unfortunately, 
they are commonly initiated late in the course of illness which contributes to poor 
outcomes, increased distress, and a failure to provide care that fulfils patients’ wishes 
(Narang, Wright, & Nicholas, 2015).  In comparison, when these discussions are early as 
is seen in palliative care, patients are more likely to receive goal-directed care that is less 
aggressive near death and have less hospitalizations, improved quality of life, and a 
greater likelihood of hospice enrollment (Mack, Weeks, Wright, Block, & Prigerson, 
2010).   
When discussing PC and advanced care planning (ACP), studies show that only 
65% of physicians felt comfortable talking with their patients about this, while 44% of 
PCPs expressed a reluctance of bringing up the topic. (Snyder, Hazelett, Allen, & 
Radwany, 2012).  These results are much higher than the 11% of providers from this 
study who expressed reluctance, suggesting the providers at this institution are 
comfortable discussing end of life care with their patients. Further research is needed to 
validate these findings. 
Well-documented reasons for PCPs to be reluctant in discussing this are they 
believe that ACP and PC discussions take too much time, could cause distress and loss of 
hope, see a referral as an acknowledgement of failure, and they do not want to abandon 
their patient (Snyder et al, 2012; Beccaro et al, 2013; Ross et al, 1996). Although many 
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studies provide evidence that PCPs need to improve their knowledge of PC in order to 
enhance the quality of care physicians provide to pts (Davis, 2013; Snyder et al, 2012; 
Beccaro et al, 2013; Ross et al, 1996), for this sample that is not true as they have 
demonstrated that they are knowledgeable. 
Limitations 
 The limitations of this study were few but of significance. The survey data is 
questionable due to the low response rate of 11.7% (n = 37) of the 316 providers invited.  
The response of the providers may have been skewed as those who chose to answer may 
be particularly interested in palliative care. Also, this survey was created from two 
different questionnaires. Questions one through four were from the PCQN that surveyed 
RNs and not providers, which could explain the difference in the average scores of 89% 
for the PCPs and 76% for the RNs.  However, questions five through eight were from a 
survey that was designed specifically to test Italian providers.  The cultural differences 
may have created the large difference between the scores. Also, the PCQN was from 
research obtained in 1996, the SKIP and SIMG from 2012.  Since then promotion and 
education of PC has grown.  
 ED utilization information excluded any acute issues, such as injuries, accidents, 
or falls. This may have eliminated patients with acute problems directly related to a 
chronic disease itself or side effects of medications taken for chronic disease or illness. 
 Also, it is unknown if these ED patients were also being seen by a specialist, such 
as a pulmonologist seeing a COPD patient, for their chronic illness or if they were being 
managed by the primary care provider. Nevertheless, the patients were still being seen in 
the ED for unmanageable symptoms of their chronic illness. This implies that they have 
unmanageable symptoms. 
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An additional limitation is the fact that it is unknown if any of these visits are the 
same patient being seen multiple times during the three-month time study period, or if 
there were any 30-day readmissions.  If this information was known, then this may have 
decreased the number of individuals seen but also would give further evidence that their 
illness is not being well managed.     
A limitation of this general population should be addressed as this healthcare 
facility is located in an area of the country with a high incidence of smokers. This may 
reflect the high rate of COPD and HTN rates which were seen in this study. Perhaps in 
another area in the country, there would possibly be different chronic illnesses that could 
change the data.  
 Lastly, it is unknown if these individuals have any other comorbidities as many 
chronic illnesses can cause other chronic illnesses to arise, such as DM and renal disease, 
that would make them inter-related. This information would have given additional 
evidence regarding diagnosis, symptom management, and causes for increased LOS or 
costs.  
Implications for Practice 
 The results of this study indicate that an early referral PCT could be beneficial to 
this community, especially with a focus on HTN and COPD.  Providers are 
knowledgeable on what PC is and the benefits it can provide for patients, yet what is of 
more significance is that many PCPs who responded would integrate it into their practice 
for their chronically ill patients. Based on the ED utilization data, the need for PC exists. 
PCPs have the knowledge and the appreciation for utilization of a palliative care team. 
This supports development of a PC team to serve primary care patients with chronic 
diseases. 
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  When surveying patients and their families regarding their chronic illness, 
research shows two major problems people face at the end of life are that quality care 
does not reach enough people (Dalal & Bruera, 2017), and the rising costs of health care 
(Dalal,et al, 2017).  PC can help to resolve these two issues when integrated, along with 
traditional treatment, at the time of diagnosis. Patient savings could amount to $2,300 to 
$8,200 (Dalal, et al, 2017) if given the opportunity to have PC as a part of their healthcare 
team, which would help to relieve that financial burden and provide them with quality 
care throughout their illness.  
Next steps could include creating a palliative care team (PCT) that a DNP 
prepared nurse practitioner could lead. This would require a thoughtful planned strategy 
to include gathering stakeholders and informing them of this project’s results, providing 
education for patients and families, and for the providers who are skeptical about PC and 
its benefits.  For the hospital leaders, administrators, and financial officers it would be 
necessary to present the evidence of how PC can improve services, decrease costs, 
increase patient satisfaction, use medical resources more efficiently and effectively, and 
promote this health system as a leader in healthcare.  Evidence of importance to present 
to these stakeholders would be the cost for creating a functional PCT and the savings that 
would be recouped.  To gain support from additional stakeholders, such as the patients, 
families, and providers, it would be necessary to hold educational sessions or forums 
explaining what PC is, how it differs from Hospice, what it can offer, how it improves 
patient satisfaction and increased QoL.  These educational sessions have the goal of 
decreasing barriers, such as PCP, patient and family resistance.  The biggest barriers 
would be a resistance to change which would require encouraging, listening and being 
available for discussions, concerns, and complaints from affected staff members. To 
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address the known unwillingness of PCPs to “share” patient and the known PCP feelings 
of abdoning their patient, as seen in the evidence (Hawley, 2017), any education or 
discussion would need to emphasize that PC is to augment care not take patients from 
providers and demonstrate how PC can increase patient satisfaction and allegiance to the 
provider especially when initiated in a timely fashion.  
Estimated costs for a successful Palliative Care Program for one hospital in this 
healthcare system would be approximately $714,000 annually.  This would include a 
breakdown of the expenses of $144,000 for office space, utilities, and supplies, and then 
an additional $570,000 for staff of one physician, two nurse practitioners, a social 
worker, and ad hoc team members. The savings that could be gained from the creation 
of a palliative care team could be recouped through a decrease in the 30-day 
readmission rates, which hospitals do not get compensated for. This savings would 
justify the annual cost for a PCT.  Although, this was not part of the study 
Savings are higher when PC is involved earlier, the hospital cost savings with PC 
involvement ranges from 9%–32% (Dalal, et al, 2017).  Patients with PC involvement 
had fewer ICU admissions, readmission rates, and approximately 32% reduction in total 
healthcare costs over 6 months post-discharge and a 50% reduction in daily charges, 
direct costs, and total costs of care for the PC patients (Scibetta, et, al. 2016).  
Early palliative care is associated with less intensive medical care, improved 
quality outcomes, and cost savings (Scibetta, et, al. 2016).  The mean total cost for 
medical care was $10,801 with PC and $16,165 without (Scibetta, et, al. 2016), which is 
an approximate savings of $5,364 per patient. This would be assuming that the average 
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patient cost was $16,165, however with the population in Kentucky the mean cost was 
$25,715. Therefore, the savings could potentially be higher.  
Recommendations for Future Studies 
Recommendations for future studies would include an examination of the 30-day 
readmission rates with and without PC involvement.  It would be beneficial to determine 
if readmission rates do decrease and provide the hospital with significant savings from 
30-day readmissions.  
Future studies could also focus on patient knowledge of PC and how they 
interpret the meaning of this specialized practice. It’s not uncommon for patients, 
families, and even providers to interchange the terms palliative care and hospice, thinking 
that they are synonymous. Research investigating pre-education and post-education of PC 
would show evidence if patient education is effective in increasing the use of PC. 
Another study could be directed at evaluating the patients’ feelings and thoughts 
regarding PC after it has been supplemented to their care team. This would be beneficial 
to verify if in fact PC does improve patient satisfaction, rather than only monitoring ER 
or hospital admissions. 
Similarly, an evaluation of PCPs’ feelings and thoughts regarding PC after it has 
been supplemented would help to understand their perspective of PC assisting in patients’ 
care.  Focus groups from PC supporters and non-supporters to discover their concerns, 
fears, and apprehensions would be helpful in determining how to best address these 
hesitations.   
Conclusion 
The evidence provided by this project demonstrates that PCPs have a high 
knowledge of PC and do find it to be of value. Also, there is evidence that patients are 
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having complications from their chronic illnesses that bring them to the ED.  By 
integrating PC earlier in an illness progression, there could be a significant impact on 
decreasing unnecessary health care utilization across this healthcare system.  PC is 
beneficial because it has been proven to reduce ED utilization and hospital admissions for 
those patients with life-limiting illness (Bushor, et al. 2015). The reduction of ED 
utilization and improved symptom management outside a hospital setting can improve 
quality of life, quality of death, and decrease overall healthcare costs. The value of early 
PC involvement is important for the patient and family to obtain the management and 
support they need to provide them with the best possible care and best possible outcomes 
that are available, but PC only provides benefits if utilized (Murphy, et al, 2013). Many 
healthcare facilities may not have a properly formed palliative care team for treating and 
caring for patients diagnosed with a life-limiting chronic illness. 
This leaves many patients and providers without the proper resources that can 
help to avoid those unnecessary hospitalizations. A PCT can focus on relieving suffering 
and achieving the best possible quality care for patients and their caregivers, while 
assisting the primary care provider with the additional support of managing their patient’s 
symptoms. Creating a PCT, one that primary care providers (PCPs) can refer chronically 
ill patients to early in the diagnosis, can provide a higher quality of overall care for all 
patients.   
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Research Office (RO)  
 224 E. Broadway  
   Louisville, KY 40202  
Phone (502) 629-3501   
  Fax (502) 629-3480  
nhora@nortonhealthcare.org  
 www.nortonhealthcare.org  
 
  
April 25, 2018  
  
Nathalie Weis, RN  
3010 Boones Trace  
Crestwood, KY 40014  
  
RO# 18-N0081 / IRB# 43022/ An assessment to determine the need for a palliative care team to improve patient satisfaction and 
decrease healthcare costs   
  
Dear Ms. Weis:  
  
The Norton Healthcare Research Office (RO) is pleased to notify you that your application to conduct the above-mentioned research 
study in the following Norton Healthcare (NHC) facility has been approved.  
  
• Norton Community Medical Associates (NCMA)  
  
Please note: Additional institutional approvals, such as from practice managers, HR, and/or Norton Medical Group, may be necessary 
based upon the type of study you are conducting. It is your responsibility to work with your advisors to ensure that all institutional 
permissions have been obtained prior to initiating your research project.  
  
The following items must be submitted to the RO if your study continues to be conducted in a NHC facility and are applicable to your 
study:  
• Annual Progress Report/Continuation Review form   
• Annual Approval letters and current Informed Consent Forms approved by the IRB, if applicable  
• Amendments and Amendment Approval letters   
• Revised HIPAA documents such as revised Partial Waivers/Complete Waivers of authorization for each change 
in personnel  
• Changes in the Conflict of Interest status  
• Status change of study, i.e. closed to enrollment, study termination etc. To comply with HIPAA regulations:  
• A copy of the Partial Waiver of Authorization must be filed with the medical record of every patient screened 
for the study, if applicable.  
• For retrospective chart reviews, a copy of the Complete Waiver of Authorization must be filed with the medical 
record of every patient whose chart is reviewed for the study.  
  
For studies utilizing an Informed Consent Form, a signed copy of the Informed Consent Form and Research Authorization must 
be filed with the medical record of each subject enrolled in your study in a NHC facility.  
  
If applicable, the Research Patient ID form must be submitted to NHC Research Billing daily with reportable activity.  Please 
email the form to  
ResearchFinance@nortonhealthcare.org.  Please contact Lori Gearhiser at 502-629-3558 for specific instructions regarding the 
notification of your subject enrollment at NHC.    
  
If the study will include the use of sponsor provided and/or personal equipment of any type (for example:  tablets, ECG machines, 
ePROs, personal laptops etc.), that equipment must be checked, tracked and/or inspected by Norton Healthcare’s Clinical 
Engineering department prior to its use or placement in a patient care setting.  Request an initial incoming inspection of the 
equipment as follows:  
  
• Norton employed researchers – contact Clinical Engineering on NSITE at 
http://nsite/departments/clinicalengineering/SitePages/Home.aspx       
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• Non-Norton employed researchers – contact Clinical Engineering by calling 502-629-3590  
  
In the event your study will utilize personal and/or sponsor provided equipment, please ensure that you comply with the procedure 
outlined above.  
  
We look forward to the successful completion of your study.  If you have any further questions or need assistance, please contact the 
RO at (502) 629-3501.  
  
Please let us know how we are doing. Follow the link https://www.surveymonkey.com/s/NHORAsatisfaction to complete the RO 
Satisfaction Survey in less than two minutes. Your feedback helps the RO improve the services we provide and meet the needs of the 
research community.  
  
Sincerely,  
  
 
Rhonda Hoffman  
System Director Research  
Norton Hospital    Norton Children’s Hospital    Norton Audubon Hospital  
Norton Women’s and Children’s Hospital     Norton Immediate Care Centers Norton Brownsboro Hospital  
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Appendix B: NHORA Approval Letter 
 
Initial Review 
Approval Ends: 3/25/2019     IRB Number: 43022 
TO: Nathalie Weis,  
PI phone #: 5027584425 
PI email: nmwe224@uky.edu 
  
 FROM: Chairperson/Vice Chairperson Medical Institutional Review Board (IRB) 
SUBJECT: Approval of Protocol DATE: 3/28/2018 
 
Initial Review 
 Approval Ends: IRB Number: 3/25/2019  
  
On 3/26/2018, the Medical Institutional Review Board approved your protocol entitled:   
An assessment to determine the need for a palliative care team to improve patient 
satisfaction and decrease healthcare costs                
Approval is effective from 3/26/2018 until 3/25/2019 and extends to any consent/assent 
form, cover letter, and/or phone script.  If applicable, the IRB approved consent/assent 
document(s) to be used when enrolling subjects can be found in the "All Attachments" 
menu item of your E-IRB application.  [Note, subjects can only be enrolled using 
consent/assent forms which have a valid "IRB Approval" stamp unless special waiver has 
been obtained from the IRB.]  Prior to the end of this period, you will be sent a 
Continuation Review Report Form which must be completed and submitted to the Office 
of Research Integrity so that the protocol can be reviewed and approved for the next 
period.    
In implementing the research activities, you are responsible for complying with IRB 
decisions, conditions and requirements.  The research procedures should be implemented 
as approved in the IRB protocol.  It is the principal investigator's responsibility to ensure 
any changes planned for the research are submitted for review and approval by the IRB 
prior to implementation.  Protocol changes made without prior IRB approval to eliminate 
apparent hazards to the subject(s) should be reported in writing immediately to the IRB.  
Furthermore, discontinuing a study or completion of a study is considered a change in the 
protocol’s status and therefore the IRB should be promptly notified in writing. 
For information describing investigator responsibilities after obtaining IRB approval, 
download and read the document "PI Guidance to Responsibilities, Qualifications, 
Records and Documentation of Human Subjects Research" available in the online Office 
of Research Integrity's IRB Survival Handbook. Additional information regarding IRB 
review, federal regulations, and institutional policies may be found through ORI's web 
site. If you have questions, need additional information, or would like a paper copy of the 
above mentioned document, contact the Office of Research Integrity at 859-257-9428. 
 
Running head: PALLIATIVE CARE NEEDS ASSESSMENT  
 
 
27 
 
Appendix C: Consent to Email PCPs 
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Appendix D: Consent/Cover Letter to PCPs 
 
IRB Approval 
3/26/2018 
IRB # 43022 
ID # 18070    
 
Email to Participants and Consent Documentation Waiver Script 
 
  You are being invited to participate in a research study, An assessment to determine the 
need for a palliative care team.  The purpose of this study will be to determine if there is a 
need for a palliative care team (PCT) to which primary care medical professionals can 
refer patients.    The Principal Investigator is Nathalie M. Weis, a student in the Doctor of 
Nursing Practice Program at the University of Kentucky College of Nursing and 
employee at Norton Healthcare.     If you agree to participate in the study, you will be 
asked to complete an online survey on Qualtrics that asks you to provide answers to nine 
questions, either true/ false, multiple choice, or yes/no.  Completing the survey will take 
approximately 5 minutes.  Your participation in this study is entirely voluntary. Your 
answers are important to us.  Of course, you have a choice about whether to complete the 
survey/questionnaire or not, but if you do participate, you are free to skip any questions 
or discontinue at any time.  There is no penalty for withdrawing and no benefits or 
services regularly afforded that you will be compromised by your participation status.   
  
There is minimal risk with participation in the study.  Qualtrics is a secure, web-based 
application designed exclusively to support data capture for research studies.   We make 
every effort to safeguard your data once received on our servers via Qualtrics. Given the 
nature of online surveys, as with anything involving the internet, we can never guarantee 
the confidentiality of data still en-route to us.    
The benefits that may be derived from this research include improving knowledge related 
to quality of care for patients with serious life-limiting illnesses through identification of 
possible treatment gaps or potential barriers. There is no direct benefit to you other than 
knowing you are informing this body of knowledge which could potentially improve 
patient care.     Your responses will be anonymous. Records of your participation in this 
study will be kept confidential to the extent permitted by law. Results of this research will 
be reported as summarized data and will not contain any identifiable individual data. For 
this study, survey respondents will not be asked to provide a name, email address or any 
identifying information.  There is no connection/link between the email addresses used 
when completing the survey and the responses.   
  
Should you have any questions you may contact Nathalie M. Weis, the Principal 
Investigator, via email at nathalie.weis@nortonhealthcare.org or telephone at 502-758-
4425.  If providers are not able to reach the PI, then they can contact the advisor, Julie 
Ossege, PhD, FNP-BC, FNAP at julianne.ossege@uky.edu. If you have any complaints, 
suggestions, or questions about your rights as a volunteer, you are asked to contact the 
staff in the Office of Research Integrity at the University of Kentucky at 859-257-9428 or 
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toll free at 1-866-400-9428 
 
Your completion of the survey will be considered your consent to participate in the study 
and your agreement that you have been sufficiently informed of the purpose of the study 
and any associated risks and benefits. If you agree to participate in the study, please click 
on the below link to access the survey.    
 
SURVEY LINK WILL BE COPIED HERE 
 
Thank you in advance for your assistance with this important project.   
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Appendix E: Survey Sent to PCPs 
 
Primary Care Physician Questionnaire:  
1-4 are true or false. 
1. Palliative care and hospice care are virtually the same.  
2. Palliative care is only appropriate in situations where there is evidence of a downhill 
trajectory or deterioration.  
3. The provision of palliative care requires emotional detachment. 
4. The philosophy of palliative care is compatible with that of aggressive treatment. 
 
5-8 are multiple choice; choose the best answer.  
5. Which of the following definitions of palliative care do you consider the most 
appropriate?  
a. A series of treatments aimed to bring the patient to a dignified end of life 
b. Pain therapy, whether moderate or severe, in the incurable patient 
c. The management of all symptoms affecting the incurable patient 
d. Holistic care, which also incorporates support for the family, for patients not only 
at the end of life but also in the developmental stage of an incurable disease 
e. Alternative treatments (e.g., homeopathy) for incurable patients and their families 
6. In your opinion, which of the following objectives is consistent with the definition of 
palliative care?  
a. To ensure the best quality of life of incurable patients 
b. To alleviate pain 
c. To relieve symptoms 
d. To prolong as long as possible the patient's life 
e. To cure the patient's illness 
7. The most authoritative guidelines on health care planning recommend that palliative care 
should be provided by:  
a. Specialized nursing staff 
b. A specialized multi-professional palliative care team that includes the family's 
GP 
c. GPs 
d. Multi-professional hospital team led by a pain therapist 
e. Specialized nursing staff in collaboration with an anesthetist 
8. According to your experience, palliative care pathways require:  
a. Treatments in accordance with the directives in the hospital discharge 
b. Diagnosis and therapy based on past experience 
c. An individual care plan. 
d. Diagnosis and therapy centered on scientific evidence 
e. High-performance technology 
 
9 and 10 are yes or no 
9. Do feel that a palliative care team, one you could refer outpatients to, is needed at Norton 
Healthcare? 
10. If available, would you refer your patients to the palliative care team? 
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Appendix F: ICD Codes  
 
Diagnosis ICD-10 Code 
Congestive Heart 
Failure 
I50.1 Left ventricular failure, unspecified 
I50.2 Systolic (congestive) heart failure 
I50.20 Unspecified systolic (congestive) heart failure 
I50.22 Chronic systolic (congestive) heart failure 
I50.3 Diastolic (congestive) heart failure 
I50.30 Unspecified diastolic (congestive) heart failure 
I50.32 Chronic diastolic (congestive) heart failure 
I50.4 Combined systolic (congestive) and diastolic (congestive) 
heart failure 
I50.40 Unspecified combined systolic (congestive) and diastolic 
(congestive) heart failure 
I50.42 Chronic combined systolic (congestive) and diastolic 
(congestive) heart failure 
I50.9 Heart failure, unspecified 
Hypertension I10 Essential (primary) hypertension  
I11 Hypertensive heart disease  
I11.0 Hypertensive heart disease with heart failure 
I11.9 Hypertensive heart disease without heart failure 
I12 Hypertensive chronic kidney disease 
I12.0 Hypertensive chronic kidney disease with stage 5 chronic 
kidney disease or end stage renal disease 
I12.9 Hypertensive chronic kidney disease with stage 1 through 
stage 4 chronic kidney disease, or unspecified chronic kidney 
disease  
I13 Hypertensive heart and chronic kidney disease 
I13.0 Hypertensive heart and chronic kidney disease with heart 
failure and stage 1 through stage 4 chronic kidney disease, or 
unspecified chronic kidney disease 
I13.1 Hypertensive heart and chronic kidney disease without heart 
failure 
I13.10 …… with stage 1 through stage 4 chronic kidney disease, 
or unspecified chronic kidney disease 
I13.11 …… with stage 5 chronic kidney disease, or end stage 
renal disease 
I13.2 Hypertensive heart and chronic kidney disease with heart 
failure and with stage 5 chronic kidney disease, or end stage renal 
disease 
I15 Secondary hypertension 
I15.0 Renovascular hypertension 
I15.1 Hypertension secondary to other renal disorders 
I15.2 Hypertension secondary to endocrine disorders 
I15.8 Other secondary hypertension 
I15.9 Secondary hypertension, unspecified 
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I16 Hypertensive crisis 
I16.0 Hypertensive urgency 
I16.1 Hypertensive emergency 
I16.9 Hypertensive crisis, unspecified 
End stage renal 
failure 
N18 Chronic kidney disease (CKD) 
N18.6 End stage renal disease 
N18.9 Chronic kidney disease, unspecified 
Chronic 
Obstructive 
Pulmonary 
Disease 
J40 Bronchitis, not specified as acute or chronic  
J41 Simple and mucopurulent chronic bronchitis  
J41.0 Simple chronic bronchitis  
J41.1 Mucopurulent chronic bronchitis  
J41.8 Mixed simple and mucopurulent chronic bronchitis  
J42 Unspecified chronic bronchitis  
J43 Emphysema  
J43.0 Unilateral pulmonary emphysema [MacLeod's syndrome]  
J43.1 Panlobular emphysema  
J43.2 Centrilobular emphysema  
J43.8 Other emphysema  
J43.9 Emphysema, unspecified  
J44 Other chronic obstructive pulmonary disease  
J44.0 Chronic obstructive pulmonary disease with acute lower 
respiratory infection  
J44.1 Chronic obstructive pulmonary disease with (acute) 
exacerbation  
J44 Other chronic obstructive pulmonary disease  
J44.0 Chronic obstructive pulmonary disease with acute lower 
respiratory infection  
J44.1 Chronic obstructive pulmonary disease with (acute) 
exacerbation  
J44.9 Chronic obstructive pulmonary disease, unspecified  
J44.9 Chronic obstructive pulmonary disease, unspecified  
J45 Asthma  
J45.2 Mild intermittent asthma  
J45.20 …… uncomplicated  
J45.22 …… with status asthmaticus  
J45.3 Mild persistent asthma  
J45.30 …… uncomplicated  
J45.32 …… with status asthmaticus  
J45.4 Moderate persistent asthma  
J45.40 …… uncomplicated  
J60 Coalworker's pneumoconiosis 
J61 Pneumoconiosis due to asbestos and other... 
J62 Pneumoconiosis due to dust containing si... 
J63 Pneumoconiosis due to other inorganic du... 
J64 Unspecified pneumoconiosis 
J65 Pneumoconiosis associated with tuberculo... 
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J66 Airway disease due to specific organic d... 
J67 Hypersensitivity pneumonitis due to orga... 
J68 Respiratory conditions due to inhalation... 
J69 Pneumonitis due to solids and liquids 
J70 Respiratory conditions due to other exte... 
J70.1Chronic and other pulmonary manifestations due to radiation 
J70.3Chronic drug-induced interstitial lung disorders 
J70.4Drug-induced interstitial lung disorders, unspecified 
J70.5Respiratory conditions due to smoke inhalation 
J70.8Respiratory conditions due to other specified external agents 
J70.9Respiratory conditions due to unspecified external agent 
Dementia  F03 Unspecified dementia 
F03.90 …… without behavioral disturbance 
F03.91 …… with behavioral disturbance 
Amyotrophic 
Lateral Sclerosis 
(aka: Lou Gehrig's 
Disease) 
G12.21 Amyotrophic lateral sclerosis 
Acquired 
Immunodeficiency 
Syndrome   
 
D84.9 Immunodeficiency, unspecified 
 
Human 
Immunodeficiency 
Syndrome 
B20 Human immunodeficiency virus [HIV] disease 
Cerebral Vascular 
Accident (aka: 
Stroke) 
I63 Cerebral infarction 
I63.9 Cerebral infarction, unspecified 
G46 Vascular syndromes of brain in cerebrovascular diseases  
G46.0 Middle cerebral artery syndrome  
G46.1 Anterior cerebral artery syndrome  
G46.2 Posterior cerebral artery syndrome  
G46.3 Brain stem stroke syndrome  
G46.4 Cerebellar stroke syndrome  
G46.5 Pure motor lacunar syndrome  
G46.6 Pure sensory lacunar syndrome  
G46.7 Other lacunar syndromes  
G46.8 Other vascular syndromes of brain in cerebrovascular 
diseases Z86.73 Personal history of transient ischemic attack 
(TIA), and cerebral infarction without residual deficits 
Diabetes Mellitus: 
type 1 
E10.1 - Type 1 diabetes mellitus with ketoacidosis  
E10.10 - Type 1 diabetes mellitus with ketoacidosis without coma  
E10.11 - Type 1 diabetes mellitus with ketoacidosis with coma  
E10.2 - Type 1 diabetes mellitus with kidney complications  
E10.21 - Type 1 diabetes mellitus with diabetic nephropathy  
E10.22 - Type 1 diabetes mellitus with diabetic chronic kidney 
disease  
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E10.29 - Type 1 diabetes mellitus with other diabetic kidney 
complication  
E10.4 - Type 1 diabetes mellitus with neurological complications  
E10.40 - Type 1 diabetes mellitus with diabetic neuropathy, 
unspecified  
E10.41 - Type 1 diabetes mellitus with diabetic mononeuropathy  
E10.42 - Type 1 diabetes mellitus with diabetic polyneuropathy  
E10.43 - Type 1 diabetes mellitus with diabetic autonomic 
(poly)neuropathy  
E10.44 - Type 1 diabetes mellitus with diabetic amyotrophy  
E10.49 - Type 1 diabetes mellitus with other diabetic neurological 
complication  
E10.5 - Type 1 diabetes mellitus with circulatory complications  
E10.51 - Type 1 diabetes mellitus with diabetic peripheral 
angiopathy without gangrene  
E10.52 - Type 1 diabetes mellitus with diabetic peripheral 
angiopathy with gangrene  
E10.59 - Type 1 diabetes mellitus with other circulatory 
complications  
E10.62 - Type 1 diabetes mellitus with skin complications  
E10.620 - Type 1 diabetes mellitus with diabetic dermatitis  
E10.621 - Type 1 diabetes mellitus with foot ulcer  
E10.622 - Type 1 diabetes mellitus with other skin ulcer  
E10.628 - Type 1 diabetes mellitus with other skin complications  
E10.64 - Type 1 diabetes mellitus with hypoglycemia  
E10.641 - Type 1 diabetes mellitus with hypoglycemia with coma  
E10.649 - Type 1 diabetes mellitus with hypoglycemia without 
coma  
E10.65 - Type 1 diabetes mellitus with hyperglycemia  
E10.69 - Type 1 diabetes mellitus with other specified 
complication  
E10.8 - Type 1 diabetes mellitus with unspecified complications  
E10.9 - Type 1 diabetes mellitus without complications 
Diabetes Mellitus: 
type 2 
E11.0 - Type 2 diabetes mellitus with hyperosmolarity  
E11.00 - Type 2 diabetes mellitus with hyperosmolarity without 
nonketotic hyperglycemic-hyperosmolar coma (NKHHC)  
E11.01 - Type 2 diabetes mellitus with hyperosmolarity with 
coma  
E11.1 - Type 2 diabetes mellitus with ketoacidosis  
E11.10 - Type 2 diabetes mellitus with ketoacidosis without coma  
E11.11 - Type 2 diabetes mellitus with ketoacidosis with coma  
E11.2 - Type 2 diabetes mellitus with kidney complications  
E11.21 - Type 2 diabetes mellitus with diabetic nephropathy  
E11.22 - Type 2 diabetes mellitus with diabetic chronic kidney 
disease  
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E11.29 - Type 2 diabetes mellitus with other diabetic kidney 
complication  
E11.4 - Type 2 diabetes mellitus with neurological complications  
E11.40 - Type 2 diabetes mellitus with diabetic neuropathy, 
unspecified  
E11.41 - Type 2 diabetes mellitus with diabetic mononeuropathy  
E11.42 - Type 2 diabetes mellitus with diabetic polyneuropathy  
E11.43 - Type 2 diabetes mellitus with diabetic autonomic 
(poly)neuropathy  
E11.44 - Type 2 diabetes mellitus with diabetic amyotrophy  
E11.49 - Type 2 diabetes mellitus with other diabetic neurological 
complication  
E11.5 - Type 2 diabetes mellitus with circulatory complications  
E11.51 - Type 2 diabetes mellitus with diabetic peripheral 
angiopathy without gangrene  
E11.52 - Type 2 diabetes mellitus with diabetic peripheral 
angiopathy with gangrene  
E11.59 - Type 2 diabetes mellitus with other circulatory 
complications  
E11.6 - Type 2 diabetes mellitus with other specified 
complications  
E11.61 - Type 2 diabetes mellitus with diabetic arthropathy  
E11.610 - Type 2 diabetes mellitus with diabetic neuropathic 
arthropathy  
E11.618 - Type 2 diabetes mellitus with other diabetic arthropathy  
E11.62 - Type 2 diabetes mellitus with skin complications  
E11.620 - Type 2 diabetes mellitus with diabetic dermatitis  
E11.621 - Type 2 diabetes mellitus with foot ulcer  
E11.622 - Type 2 diabetes mellitus with other skin ulcer  
E11.628 - Type 2 diabetes mellitus with other skin complications  
E11.64 - Type 2 diabetes mellitus with hypoglycemia  
E11.641 - Type 2 diabetes mellitus with hypoglycemia with coma  
E11.649 - Type 2 diabetes mellitus with hypoglycemia without 
coma  
E11.65 - Type 2 diabetes mellitus with hyperglycemia  
E11.69 - Type 2 diabetes mellitus with other specified 
complication  
E11.8 - Type 2 diabetes mellitus with unspecified complications  
E11.9 - Type 2 diabetes mellitus without complications 
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Table 1: Provider survey and answers 
 
Survey question Sample 
answered 
correctly 
PCQN 
answered 
correctly 
SCIP and SIMG 
answered 
correctly 
1. Palliative  
care and hospice care are virtually the same.  answer 
False 
89% 87%  
2. Palliative 
care is only appropriate in situations where there is 
evidence of a downhill 
trajectory or deterioration.  
answer False 
86% 85%  
3. The 
provision of palliative care requires emotional 
detachment.  
answer False 
100% 85%  
4. The philosophy of palliative care is compatible with 
that of aggressive 
treatment.  
answer True 
84% 47.7%  
5. Which of the following definitions of palliative care 
do you consider the most appropriate?  
answer D. Holistic care, which also incorporates 
support for family, patients, not only for the end of life 
but also in the developmental stages of an incurable 
disease.  
86%  25.5% 
6. In your opinion, which of the following objectives is 
consistent with the definition of palliative care?  
answer To ensure the best quality of life of incurable 
patients.  
92%  40.6% 
7. The most authoritative guidelines on health care 
planning recommend that palliative care should be 
provided by:  
answer A specialized multiprofessional palliative care 
team that includes the family’s GP.  
97%  65.5% 
8. According to your experience, palliative care 
pathways require:  
answer An individual care plan. 
45%  59.5% 
9. If available, would you refer your patients to the 
palliative care team?  
answer Yes 
89%   
10. What is your professional title? 
Answer APRN 
49%   
Survey questions and answers from this study compared to results from research of 
the PCQN and the SCIP/SIMG 
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Table 2. Patient demographics 
 
Characteristics Mean (SD); range 
 or n (%) 
Age 61.6 (16.8); 18 – 101 
Gender 
   Female  
   Male 
 
1,365 (56.1%) 
1,068 (43.9%) 
Race 
   White 
   Black 
   Other 
 
1,581 (65%) 
777 (31.9%) 
75 (3.1%) 
Insurance status 
   Medicare 
   Private  
   Medicaid 
   Self-pay 
   Other 
   Hosparus Scatter Bed  
 
1,375 (56.5%) 
450 (18.5%) 
175 (7.2%) 
65 (2.7%) 
52 (2.1%) 
4 (0.2%) 
Diagnosis 
   Hypertension 
   COPD  
   Diabetes  
   Congestive Heart Failure 
   Cerebral Vascular Accident  
   Dementia 
   HIV 
   Renal Disease 
 
910 (37.4%) 
556 (22.9%) 
483 (19.9%) 
255 (10.5%) 
199 (8.2%) 
20 (0.8%) 
8 (0.3%) 
2 (0.1%) 
Patient Status    
   Admitted to Hospital  
   ED Visit and Discharged 
   Expired 
 
1,524 (62.6%) 
909 (37.4%) 
26 (0.01%) 
Descriptive summary of the ED utilization data of study sample (N =2,433) 
 
A total of 2433 adults presented to the ED due to complications from CHF, HTN, ESR, 
COPD, dementia, ALS, AIDS, HIV, CVA, DM.  The average age was 61.6 years (SD = 
16.8).   
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Table 3: National Data 
 
Characteristics n (%) per 1,000 for 
the year 2015 
n per 1,000 for 
three months 
Gender 
   Male 
   Female 
 
29,406 (42.4%) 
39,980 (57.6%) 
 
7,352 
9,995 
Race 
   White 
   Black 
   Other 
 
51,414 (74%) 
15,908 (23%) 
2,063 (3%) 
 
12,854 
3,977 
516 
Insurance status 
   Medicare 
   Medicaid 
   Private 
   Self-pay 
   Other 
 
18,471 
24,122 (34.8%) 
23,780 
6,215 
2,780 
 
4,618 
6,031 
5,945 
1,554 
695 
Diagnosis 
   Congestive Heart Failure 
   COPD 
   Dementia 
   Cerebral Vascular Accident 
   Diabetes 
   HIV 
   Hypertension 
   Renal Disease 
 
4,413 (6.4%) 
7,251 (10.5%) 
1,712 (2.5%) 
4,002 (5.8%) 
14,945 (21.6%) 
566 (0.8%) 
32,370 (46.7%) 
4,082 (5.9%) 
 
1,103 
1,813 
428 
1,001 
3,736 
142 
8,093 
1,021 
Patient Status    
   Emergency Department Visit and 
Discharge 
   Admitted to Hospital 
   Expired 
 
69,341 
7,280 (10.5%) 
188(0.3%) 
 
17,335 
1,820 
47 
National data of ED usage in 2015 (N = 69,341 per 1,000 for 12 months; N = 17,335 
per 1,000 for three months). 
 
Centers for Disease Control and Prevention. (2015). National Hospital Ambulatory 
Medical Care Survey: 2015 Emergency Department Summary Tables. Data extracted 
for 69,341,000 patients with specific diagnoses of CHF, HTN, ESR, COPD, dementia, 
ALS, AIDS, HIV, CVA, DM.   
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Table 4: This study’s data compared to national data 
 
Characteristics This study 
n (%) 
National  
n (%) per 1,000 
for three 
months 
National data 
n (%) per 1,000 
for the year 
2015 
Gender 
   Female  
   Male 
 
1,365 (56.1%) 
1,068 (43.9%) 
 
9,995 (57.6%)  
7,352 (42.4%) 
 
39,980 (57.6%) 
29,406 (42.4%) 
Race 
   Caucasian  
   African American 
   Other 
 
1,581 (65%) 
777 (31.9%) 
75 (3.1%) 
 
12,854 (74%) 
3,977 (23%) 
516 (3%) 
 
51,414 (74%) 
15,908 (23%) 
2,063 (3%) 
Insurance status 
   Medicare 
    Private  
    Medicaid 
    Self-pay  
    Other 
    Hosparus Scatter Bed  
 
1,375 (56.5%) 
450 (18.5%) 
175 (7.2%) 
65 (2.7%) 
52 (2.1%) 
4 (0.2%) 
 
4,618 (26.7%) 
5,945 (34.3%) 
6,031 (34.8%) 
695 (4%) 
1,554 (9%) 
 
18,471 (26.7%) 
23,780 (34.3%) 
24,122 (34.8%) 
2,780 (4%) 
6,215 (9%) 
Diagnosis 
   Hypertension  
   COPD  
   Diabetes  
   Congestive Heart Failure 
   Cerebral Vascular Accident   
   Dementia 
   HIV 
   Renal Disease 
 
910 (37.4%) 
556 (22.9%) 
483 (19.9%) 
255 (10.5%) 
199 (8.2%) 
20 (0.8%) 
8 (0.3%) 
2 (0.1%) 
 
8,093 (46.7%) 
1,813 (10.5%) 
3,736 (21.6%) 
1,103 (6.5%) 
1,001 (5.8%) 
428 (2.5%) 
142 (0.8%) 
1,021 (5.9%) 
 
32,370 (46.7%) 
7,251 (10.5%) 
14,945 (21.6%) 
4,413 (6.5%) 
4,002 (5.8%) 
1,712 (2.5%) 
566 (0.8%) 
4,082 (5.9%) 
Patient Status    
   Admitted to Hospital  
   Emergency Department 
Visit 
         and Discharge 
   Expired 
 
1,524 (62.6%) 
 
909 (37.4%) 
26 (0.01%) 
 
1,820 (10.5%) 
 
15,515 (89.5%)  
47 (0.3%) 
 
7,280 (10.5%) 
 
62,061 (89.5%) 
188(0.3%) 
Table 4: ED utilization from this study compared to National data of ED usage in 
2015 (N = 69,341 per 1,000 for 12 months; N = 17,335 per 1,000 for three months). 
 
Centers for Disease Control and Prevention. (2015). National Hospital Ambulatory 
Medical Care Survey: 2015 Emergency Department Summary Tables. Data extracted 
for 69,341 patients with specific diagnoses of CHF, HTN, ESR, COPD, dementia, ALS, 
AIDS, HIV, CVA, DM.   
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Figure 1: Original palliative care model 
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Figure 2: Evidence-based updated model of palliative care 
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Figure 3: Cost per diagnosis of ED utilization data 
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Figure 4: Mean cost per patient 
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